Heart Failure
Birmingham
Date:
4th December 2018
Cost:
Free
Empowering clinical pharmacists to manage heart failure and hypertension effectively and improve outcomes for patients
Our interactive workshops will combine expert speakers and sharing of best practice by our clinical pharmacist facilitators who are conducting Heart Failure and Hypertension related services in their own practices.
The Heart Failure & Hypertension i2i program is fully funded by Novartis Pharmaceuticals UK Limited. All content has been developed by Soar Beyond with input from the expert faculty.
Speakers
Agenda
Supported by
Speakers
Helen Williams
Helen Williams FFRPS, FRPharmS – National Specialty Adviser for CVD Prevention, NHSE and I, Consultant Pharmacist for Cardiovascular Disease, South East London CCG, Clinical Lead for Cardiovascular Disease, Southwark and Lambeth CCGs, Clinical Lead for AF, North Central London, UCLPartners.
Helen has worked as a CVD specialist for the past 25 years in hospital, community and primary care settings. She has spearheaded a wide range of activities across South London and beyond to improve the care of patients with or at risk of cardiovascular disease (CVD).
Read BioNipa Patel
Nipa Patel is a Senior PCN pharmacist for SASSE2 in Surrey Heartlands with vast experience across community pharmacy, medicines management, practice pharmacy and even urgent care pharmacy roles.
Read BioRocco Hadland
Rocco works as a Primary Care Network clinical pharmacist for South Wirral PCN as well as being part of the GP clinical pharmacist integrated team between Wirral University Teaching Hospital and GP practices across the Wirral. He is a member of the UK Clinical Pharmacy Association (UKCPA) heart failure committee, and a member of the editorial advisory board for the Clinical Pharmacist journal.
Read Bio
Agenda
The workshop will focus on ‘insight’ in the morning and on ‘implementation’ the afternoon. The day has been structured to allow plenty of networking time and activities
Supported by
This programme is funded by Novartis. Novartis has not had any input into the content or involvement in the creation of these materials. All materials have been developed by the i2i Network Faculty. Soar Beyond owns all intellectual property rights for the resources and training and retains editorial rights at all times.
This workshop has already taken place.